CG
FOLD

Cutler Group’s Amicus Therapeutics FOLD Stock Holding History

Cutler Group’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-200
Closed -$2K – 4091
2022
Q4 		$2K Buy
+200
New +$2.25K ﹤0.01% 3679
2020
Q1 		– Sell
-5,099
Closed -$49K – 4205
2019
Q4 		$49K Buy
+5,099
New +$46.7K ﹤0.01% 1638
2018
Q2 		– Sell
-20,746
Closed -$314K – 4411
2018
Q1 		$312K Buy
20,746
+1,982
+11% +$30.2K 0.03% 597
2017
Q4 		$270K Sell
18,764
-18,011
-49% -$247K 0.01% 808
2017
Q3 		$554K Buy
36,775
+33,175
+922% +$439K 0.02% 609
2017
Q2 		$36K Buy
3,600
+3,346
+1,317% +$26.9K ﹤0.01% 2811
2017
Q1 		$1K Sell
254
-29,928
-99% -$189K ﹤0.01% 5830
2016
Q4 		$150K Buy
30,182
+23,514
+353% +$163K 0.01% 1551
2016
Q3 		$49K Sell
6,668
-266
-4% -$1.8K ﹤0.01% 2484
2016
Q2 		$37K Sell
6,934
-284
-4% -$1.99K ﹤0.01% 2672
2016
Q1 		$60K Sell
7,218
-4,059
-36% -$28.7K ﹤0.01% 2127
2015
Q4 		$109K Buy
+11,277
New +$102K 0.01% 1678

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Cutler Group's FOLD Position: Q1 2023 in Review

Cutler Group sold out of Amicus Therapeutics (FOLD) in Q1 2023, closing a stake of 200 shares — an estimated $2K sold.

Cutler Group first reported a position in FOLD in Q4 2015 and held it in 12 quarters. The position peaked at $554K in Q3 2017. 226 funds tracked by Wall St. Rank hold FOLD as of Q1 2023.

  • Cutler Group reported no remaining Amicus Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 200 Amicus Therapeutics shares in Q1 2023, an estimated $2K.
  • Cutler Group first reported a position in Amicus Therapeutics in Q4 2015 and held it in 12 quarters.
  • Cutler Group's Amicus Therapeutics position peaked at $554K in Q3 2017.
  • 226 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.